| Literature DB >> 24643088 |
Sina Kohl1, Carolin Wolters1, Theo O J Gruendler2, Kai Vogeley3, Joachim Klosterkötter1, Jens Kuhn1.
Abstract
BACKGROUND: High functioning autism is an autism spectrum disorder that is characterized by deficits in social interaction and communication as well as repetitive and restrictive behavior while intelligence and general cognitive functioning are preserved. According to the weak central coherence account, individuals with autism tend to process information detail-focused at the expense of global form. This processing bias might be reflected by deficits in sensorimotor gating, a mechanism that prevents overstimulation during the transformation of sensory input into motor action. Prepulse inhibition is an operational measure of sensorimotor gating, which indicates an extensive attenuation of the startle reflex that occurs when a startling pulse is preceded by a weaker stimulus, the prepulse.Entities:
Mesh:
Year: 2014 PMID: 24643088 PMCID: PMC3958534 DOI: 10.1371/journal.pone.0092372
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Participants' characteristics.
| HFA group | Control group | Statistical differences | |||||
|
|
| Range |
| Range |
|
|
|
|
| 40.2 (9.93) | 23–53 | 43.4 (10.55) | 26–56 | .090 | 32 | .373 |
|
| 18.2 (5.48) | 10–30 | 20.4 (3.35) | 15–27 | 1.38 | 32 | .178 |
|
| 116.4 (16.14) | 89–143 | 119.2 (7.0) | 101–133 | .66 | 22 | .515 |
|
| 11 (9.76) | 0–34 | 5.1 (4.98) | 0–15 | 2.24 | 24 | .035* |
|
| 41.1 (3.64) | 34–45 | 15.9 (7.05) | 5–29 | 13.09 | 24 | <.001* |
|
| 16.9 (7.82) | 6–30 | 42.4 (12.83) | 21–65 | 3.77 | 23 | <.001* |
|
| 37.3 (15.42) | 11–67 | 21.7 (7.24) | 11–36 | 7.01 | 32 | <.001* |
HFA = High functioning autism; Education = Years of education; IQ = Intelligence Quotient; BDI = Beck Depression Inventory; AQ = Autism Quotient; EQ = Empathy Quotient; SQ = Systemizing Quotient; *significant at an alpha level of .05.
Medication.
| Number of participants | Medication |
| 5 (HFA), 1 (NC) | Antidepressant drug (2× Sertraline, 2× Mirtazepine, |
| 1× Citalopram, 1× Moclobemid) | |
| 2 (HFA), 1 (NC) | Beta blocker (1× Bisoprolol, 1× Metahexal, |
| 1× Mesoprolol) | |
| 1 (HFA), 1 (NC) | Irbesartan |
| 1 (NC) | Ramiprile |
| 1 (HFA) | Lamotrigine |
HFA = High functioning autism; NC = normal controls.
Figure 1PPI scores.
Mean PPI scores (± SEM) across the three trial conditions in subjects with high functioning autism (HFA) and normal control (NC) subjects.
Figure 2Startle amplitudes and habituation rates.
Habituation rates across the four blocks of trials in the high functioning autism (HFA) and normal control (NC) group. Mean startle amplitudes (± SEM) of each five pulse-alone trials are shown. HFA participants showed significantly higher absolute startle amplitudes compared to NC participants, while habituation rates were similar.
Comorbid psychiatric disorders.
| Number of participants (group) | Psychiatric disorder |
| 1 (HFA) | Bipolar disorder |
| 1 (HFA) | Depression |
| 1 (HFA) | Dysthymia |
| 1 (HFA) | Anxiety Disorder |
| 2 (HFA) | ADHD |
| 1 (HFA) | ADD |
HFA = High functioning autism; ADHD = attention deficit/hyperactivity disorder; ADD = attention deficit disorder.